Hemostasis Today

June, 2026
June 2026
M T W T F S S
1234567
891011121314
15161718192021
22232425262728
2930  
Olivia C.: Pfizer’s mRNA BNT162b2 Vaccine Does Not Induce High Levels of Inflammation
Mar 26, 2026, 17:14

Olivia C.: Pfizer’s mRNA BNT162b2 Vaccine Does Not Induce High Levels of Inflammation

Olivia C., Business Development Manager at Pfizer, shared a post on LinkedIn:

“Precise data on changes in hematological parameters in vaccinated patients are essential to accurately reflect advancements in medical technology.

Infections can cause significant changes in certain hematological parameters and exacerbate inflammatory responses, such as the neutrophil-to-lymphocyte ratio (NLR), lymphocyte-to-monocyte ratio (LMR), platelet-to-lymphocyte ratio (PLR), and ferritin levels.

In contrast, Pfizer’s mRNA-based BNT162b2 vaccine does not induce high levels of inflammation.”

Olivia C.

Stay updated with Hemostasis Today.